SAN DIEGO, Feb. 1, 2011 /PRNewswire/ — CareFusion
Corporation (NYSE:
CFN), a global, medical technology company, announced today the
appointment of Kieran T. Gallahue as chairman and chief executive
officer, succeeding David L. Schlotterbeck who previously announced
plans to retire later this month.

A seasoned medical-technology executive, Mr. Gallahue, 47, was
most recently president and CEO of ResMed (NYSE:
RMD), a global leader in medical equipment for treating,
diagnosing and managing sleep-related respiratory disorders.

During his tenure, the company grew revenue approximately 500
percent to $1.2 billion, while expanding operating margins and
increasing net income more than 20 percent annually. He built an
exceptional management team and global organization that
commercialized products in more than 70 countries.

Mr. Gallahue has nearly 20 years of strategic, operational and
corporate management experience in the health care industry, with
deep expertise in the medical technologies field. Since 2007, he
has also served on the board of Volcano Corp., a developer of
products for interventional cardiology.

“Kieran brings strategic, operational and public company
experience to CareFusion, with a proven track record of growth
– all qualities that were critical in our search process,”
said J. Michael Losh, presiding director of the CareFusion board.
“CareFusion has ample opportunities to grow and innovate, as we
execute against our near-term plans to expand margins. We see a
clear path to create exponentially greater value and believe Kieran
is an ideal fit to accelerate this work.”

Mr. Gallahue said, “It is a rare opportunity to join a company
with an end-to-end portfolio of category leading products yet with
such growth

‘/>”/>

SOURCE